About 2 results.

Ubrogepant


Source: https://upload.wikimedia.org/wikipedia/commons/thumb/b/b3/Ubrogepant.svg/50px-Ubrogepant.svg.png

Description. Lang: en

Ubrogepant, sold under the trade name Ubrelvy, is a medication used for the acute (immediate) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults. It is not indicated for the preventive treatment of migraine. It is the first drug in the class of oral calcitonin gene-related peptide receptor antagonists approved for the acute treatment of migraine.The most common side effects are nausea, tiredness and dry mouth. Ubrogepant is contraindicated for co-administration with strong CYP3A4 inhibitors.It is a small-molecule calcitonin gene-related peptide receptor antagonist.
Description provided by Wikipedia.

Google Suggest

Search predictions are possible search terms you can use that are related to the terms you’re typing and what other people are searching for.

Entity Index

This is the list of all entities in this result page. Click an entity to go directly to the entity box.

Wiki Authority Control

Authority control is a method of creating and maintaining index terms for bibliographical material in a library catalogue. The links produced by the authority control template on Wikipedia go to authority control data in worldwide library catalogues.

Google Knowledge Graph

Ubrogepant

Ubrogepant

Medication

  • Desc: Ubrogepant, sold under the trade name Ubrelvy, is a medication used for the acute treatment of migraine with or without aura in adults. It is not indicated for the preventive treatment of migraine.
  • Wiki: https://en.wikipedia.org/wiki/Ubrogepant
  • Type: Thing
  • Result Score: 641.85

European Headache Federation Congress

Event

  • Type: Event, Thing
  • Result Score: 0.00
Try searching in other languages: en - it - fr - de - es - pt
Entities Finder | Cluster.army | Keyword Tool | URLs Match | Cache index

This process used 16 ms for its computations It spent 4 ms in system calls .